What It Is:

MedAff Catalyst organizes core scientific content into modular assets that can be deployed across advisory boards, medical education programs, field resources, congress activities, and digital channels while maintaining consistency, quality, and compliance.

Why It Matters:

In an environment of growing scientific complexity and expanding communication channels, MedAff Catalyst provides a structured framework that helps Medical Affairs teams coordinate scientific engagement efficiently, accelerate speed to launch, and maintain consistency across initiatives.

How It Works:

MedAff Catalyst begins by establishing a clear scientific foundation for engagement. From there, modular capabilities are activated to support advisory engagement, stakeholder insight generation, medical education, field enablement, and omnichannel communications.

Let Reverba connect you with patient communities.


The Latest

  • How Peer Mentors Help Patients Start and Stay on Therapy in Rare Disease
    How Peer Mentors Help Patients Start and Stay on Therapy in Rare Disease

    In rare disease, a missing piece in starting and staying on therapy is often lived perspective. Patients and their care partners may begin rare disease treatment with no peer reference…

  • Six Patient Engagement “Trends” We Should Have Outgrown by 2026
    Six Patient Engagement “Trends” We Should Have Outgrown by 2026

    By Cheryl Lubbert, Reverba Global CEO. A New-Year Perspective on Patient Engagement The biopharma industry talks a good game about patient engagement. We talk about personalization, digital transformation, empowerment, omnichannel…

  • Elevating Voices, Empowering Futures: Mentorship as a Catalyst for Change in Biopharma
    Elevating Voices, Empowering Futures: Mentorship as a Catalyst for Change in Biopharma

    By Cheryl Lubbert, Reverba Global CEO. In biopharma, where innovation depends on both scientific discovery and human connection, mentorship stands as one of the most powerful forces for progress. It’s…